Several key molecules in the BCR-, TLR- and NFκB signaling pathways that drive the growth of CLL cells are targets for O-GlcNAcylation including LYN, IKKβ, p65, c-REL, and TAB1 (91–95). The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.